Trial intelligence / Profile preview

Antidepressants plus mood stabilizers for maintenance treatment of bipolar depression

ChiCTR2000031256Phase 4Completed

Sponsor
Beijing Anding Hospital
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of antidepressant (TDDS/ODF) in bipolar disorder (BD) (2 arms), sponsored by Beijing Anding Hospital. Primary endpoint: Time to recurrence. Started Sep 2015; status: completed.

02

Drugs

antidepressant (TDDS/ODF)
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on ChiCTR2000031256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call